Stockscreener 앱 받기
0.8721
3.35%
-0.0302
시장 영업 전:
.87
-0.0021
-0.24%
Immunic Inc 주식(IMUX)의 최신 뉴스
Is Immunic Inc. stock a value trapInvestment Timing Signals - thegnnews.com
Technical signs of recovery in Immunic Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Will Immunic Inc. price bounce be sustainableFree Smart Trade Plans With Risk Protection - Newser
Intraday pattern recognizer results for Immunic Inc.Free Early Entry Tips With Low Risk Zone - Newser
Immunic reports promising Phase 2 data for lead drug candidate in progressive MSICYMI - Proactive financial news
Is a relief rally coming for Immunic Inc. holdersConservative Investment Setup and Risk Analysis - Newser
Immunic: Q2 Earnings Snapshot - Connecticut Post
Immunic, Inc. Advances Multiple Sclerosis Drug Trials - TipRanks
Small cap wrap: Immunic, Nextech3D.ai, EDM Resources, Alvopetro… - Proactive financial news
Immunic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Immunic CEO on strong Q2 progress with vidofludimus calcium trials for MS - Proactive financial news
Immunic advances MS drug program with Phase 3 trials fully enrolled - Proactive Investors
Immunic Advances Phase 3 Trials and Financial Health - TipRanks
Biotech Immunic Q2 net loss widens, flags need to raise cash - MarketScreener
Immunic, Inc.: A High-Potential Biotech Play in the MS and GI Therapeutics Space - AInvest
EQS-News: Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Ariva
Immunic (IMUX) to Release Quarterly Earnings on Thursday - Defense World
Immunic Inc. Stock Analysis and ForecastBreakout profit opportunities - Jammu Links News
When is Immunic Inc. stock expected to show significant growthMarket-crushing stock picks - Jammu Links News
How does Immunic Inc. compare to its industry peersMaximize gains with proven stock analysis - Jammu Links News
What is the dividend policy of Immunic Inc. stockMaximize returns with strategic portfolio planning - Jammu Links News
Should I hold or sell Immunic Inc. stock in 2025Invest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Immunic Inc. stockSuperior profit margins - Jammu Links News
What are analysts’ price targets for Immunic Inc. in the next 12 monthsTrack high-yield stocks before they peak - Jammu Links News
What institutional investors are buying Immunic Inc. stockUnstoppable investment returns - Jammu Links News
What drives Immunic Inc. stock priceGain access to exclusive stock analysis - Jammu Links News
Is it the right time to buy Immunic Inc. stockProven strategies for superior portfolio growth - Jammu Links News
Is Immunic Inc. a growth stock or a value stockBuild wealth faster with consistent investment plans - Jammu Links News
Immunic, Inc. (NASDAQ:IMUX) Receives $7.50 Consensus Target Price from Brokerages - Defense World
Published on: 2025-08-03 05:26:52 - Jammu Links News
How volatile is Immunic Inc. stock compared to the marketTurbocharged investment results - Jammu Links News
How Immunic Inc. stock performs during market volatilityAccurate Forecast System with AI Support - Newser
Why is Immunic Inc. stock attracting strong analyst attentionBreakout Stocks Opportunities That Work - jammulinksnews.com
Why Immunic Inc. stock attracts strong analyst attentionDaily Chart Pattern Stock Forecast Shows Bullish Setup - beatles.ru
Multiple Sclerosis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Novartis, Sanofi, Immunic, Biocad, Apimeds, Genentech (Roche), Merck, AB Scie - Menafn
What is Immunic Inc. company’s growth strategyBreakthrough profit margins - Jammu Links News
What are the technical indicators suggesting about Immunic Inc.Free Consultation - jammulinksnews.com
0.24%
3.39%
자본화:
|
볼륨(24시간):